144 related articles for article (PubMed ID: 12880282)
1. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.
Gittens SA; Matyas JR; Zernicke RF; Uludağ H
Pharm Res; 2003 Jul; 20(7):978-87. PubMed ID: 12880282
[TBL] [Abstract][Full Text] [Related]
2. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
3. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
4. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
6. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
7. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
8. Targeting systemically administered proteins to bone by bisphosphonate conjugation.
Uludag H; Yang J
Biotechnol Prog; 2002; 18(3):604-11. PubMed ID: 12052079
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols.
Zhang S; Wright JE; Bansal G; Cho P; Uludag H
Biomacromolecules; 2005; 6(5):2800-8. PubMed ID: 16153121
[TBL] [Abstract][Full Text] [Related]
10. Bone affinity of a bisphosphonate-conjugated protein in vivo.
Uludag H; Gao T; Wohl GR; Kantoci D; Zernicke RF
Biotechnol Prog; 2000; 16(6):1115-8. PubMed ID: 11101342
[TBL] [Abstract][Full Text] [Related]
11. A di(bisphosphonic acid) for protein coupling and targeting to bone.
Bansal G; Gittens SA; Uludağ H
J Pharm Sci; 2004 Nov; 93(11):2788-99. PubMed ID: 15368528
[TBL] [Abstract][Full Text] [Related]
12. Imparting mineral affinity to proteins with thiol-labile disulfide linkages.
Bansal G; Wright JE; Zhang S; Zernicke RF; Uludag H
J Biomed Mater Res A; 2005 Sep; 74(4):618-28. PubMed ID: 16037953
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin.
Bhandari KH; Newa M; Uludag H; Doschak MR
Int J Pharm; 2010 Jul; 394(1-2):26-34. PubMed ID: 20412845
[TBL] [Abstract][Full Text] [Related]
14. Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis.
Doschak MR; Kucharski CM; Wright JE; Zernicke RF; Uludağ H
Mol Pharm; 2009; 6(2):634-40. PubMed ID: 19718808
[TBL] [Abstract][Full Text] [Related]
15. Potent antigen-specific immune response induced by infusion of spleen cells coupled with succinimidyl-4-(N-maleimidomethyl cyclohexane)-1-carboxylate (SMCC) conjugated antigens.
Guo Y; Werbel T; Wan S; Wu H; Li Y; Clare-Salzler M; Xia CQ
Int Immunopharmacol; 2016 Feb; 31():158-68. PubMed ID: 26735611
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates.
Peeters JM; Hazendonk TG; Beuvery EC; Tesser GI
J Immunol Methods; 1989 Jun; 120(1):133-43. PubMed ID: 2499636
[TBL] [Abstract][Full Text] [Related]
17. 2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation.
Dovgan I; Kolodych S; Koniev O; Wagner A
Sci Rep; 2016 Aug; 6():30835. PubMed ID: 27501860
[TBL] [Abstract][Full Text] [Related]
18. Commercially Supplied Amine-Modified siRNAs May Require Ultrafiltration prior to Conjugation with Amine-Reactive Compounds.
Lau S; Graham B; Boyd BJ; Pouton CW; White PJ
J Nucleic Acids; 2011; 2011():154609. PubMed ID: 21772990
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
Ehrlich GK; Michel H; Truitt T; Riboulet W; Pop-Damkov P; Goelzer P; Hainzl D; Qureshi F; Lueckel B; Danho W; Conde-Knape K; Konkar A
Bioconjug Chem; 2013 Dec; 24(12):2015-24. PubMed ID: 24251972
[TBL] [Abstract][Full Text] [Related]
20. A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.
Meckel M; Kubíček V; Hermann P; Miederer M; Rösch F
Nucl Med Biol; 2016 Nov; 43(11):670-678. PubMed ID: 27560354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
